Gi Hyun Lee

Title: Gi Hyun Lee: Inventor in Biomedical Research

Introduction

Gi Hyun Lee is an inventor based in Seoul, South Korea. His patent work includes research into bee venom phospholipase A2 and its potential use in treatments related to regulatory T-cell activity. His portfolio includes 3 patents.

Latest Patents

One of Lee’s listed inventions concerns a pharmaceutical composition containing bee venom phospholipase A2 (BV-PLA2), a polypeptide based on the enzyme’s amino acid sequence without its leader sequence. The patent description states that the compound may activate regulatory T cells and suppress the differentiation of Th1 and Th17 cells. It proposes potential applications in treating or preventing autoimmune, allergic, and neurodegenerative diseases associated with abnormal regulatory T-cell activity.

The supplied patent information lists this invention twice under slightly different titles. Both descriptions present the same core concept and proposed therapeutic applications.

Career Highlights

Lee’s listed professional affiliations include Inist St Co., Ltd. and the University-Industry Cooperation Group of Kyung Hee University. These affiliations connect his work with both a company and a university-industry collaboration group.

Collaborations

Hyo Jung Lee and Eun Sook Chung are identified as Lee’s coworkers. The supplied information does not specify their roles in the listed patent work.

Conclusion

Gi Hyun Lee’s patent portfolio highlights biomedical research into BV-PLA2 as a potential approach to diseases involving disrupted regulatory T-cell activity.